Decades after an individual’s first unexplained seizure, a genetic diagnosis can still provide the clarity that they have been waiting for, and the chance for better outcomes.¹ It’s also more accessible than ever.
We value your feedback! Take our quick client satisfaction survey here.
Decades after an individual’s first unexplained seizure, a genetic diagnosis can still provide the clarity that they have been waiting for, and the chance for better outcomes.¹ It’s also more accessible than ever.
This Epilepsy Awareness Month, prioritize genetic testing Up to 50% of unexplained epilepsy is genetic, making exome testing a crucial first step for answers
Learn how exome and genome sequencing can impact care for patients with epilepsy and cerebral palsy.
Join us at upcoming conferences to connect and discuss the future of exome and genome sequencing. Missed a recent event? Click on a past conference below to see what we presented.
Learn why an expert on neurogenetics and rare disease recommends ordering exome for patients. Join Dr. Isabella Herman as she explains the importance of exome sequencing at this webinar.
The American Epilepsy Society (AES) endorses the NSGC guideline recommending exome or genome sequencing for individuals with:3